Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2021 Dec 23;31(4):467–475. doi: 10.1002/pds.5398

TABLE 2.

Positive predictive values comparing algorithms of ICD-9 and ICD-10 claims-based diagnoses of CKD Stages 3–5 to eGFR based on laboratory values

Algorithm ICD-9 period 2012–2014 ICD-10 period 2016–2018
1 CKD diagnosis, lab ± 90 days N = 146 739 N = 380 117

PPV (%), 95% CI
 Comparison to eGFR (CKD-EPI) 81.24 (81.04, 81.44) 82.00 (81.87, 82.12)
 Comparison to eGFR (MDRD) 81.89 (81.70, 82.09) 82.03 (81.91, 82.15)

2 CKD diagnoses, lab ± 90 days N = 104 774 N = 285 520

PPV (%), 95% CI
 Comparison to eGFR (CKD-EPI) 86.36 (86.15, 86.57) 86.07 (85.94, 86.20)
 Comparison to eGFR (MDRD) 86.67 (86.47, 86.88) 85.93 (85.80, 86.06)

1 CKD diagnosis, lab ± 180 days N = 155 730 N = 386 331

PPV (%), 95% CI
 Comparison to eGFR (CKD-EPI) 80.32 (80.12, 80.52) 81.56 (81.43, 81.68)
 Comparison to eGFR (MDRD) 80.91 (80.71, 81.10) 81.46 (81.34, 81.59)

2 CKD diagnoses, lab ± 180 days N = 110 540 N = 286 745

PPV (%), 95% CI
 Comparison to eGFR (CKD-EPI) 85.30 (85.09, 85.51) 85.56 (85.43, 85.69)
 Comparison to eGFR (MDRD) 85.60 (85.40, 85.81) 85.30 (85.17, 85.43)

1 CKD diagnosis, lab ± 365 days N = 161 305 N = 373 220

PPV (%), 95% CI
 Comparison to eGFR (CKD-EPI) 78.80 (78.61, 79.00) 80.63 (80.50, 80.76)
 Comparison to eGFR (MDRD) 79.21 (79.01, 79.41) 80.40 (80.27, 80.52)

2 CKD diagnoses, lab ± 365 days N = 111 329 N = 270 553

PPV (%), 95% CI
 Comparison to eGFR (CKD-EPI) 84.06 (83.84, 84.27) 84.81 (84.67, 84.94)
 Comparison to eGFR (MDRD) 84.12 (83.91, 84.34) 84.41 (84.27, 84.54)

Note: Lab assessment window is described by the X-days lab label. For example, the 90-days lab label describes an analysis in which patients had a creatinine laboratory value 90 days before or after their claims-based CKD diagnosis.

Abbreviations: CKD-EPI, chronic kidney disease epidemiology collaboration; MDRD, the modification of diet in renal disease.